biotech hires

R&D

There was plenty of movement at the top of pharma and biotech in September, with leadership changes spanning some of the industry’s biggest names.

R&D

August brought another wave of leadership changes across biotech, pharma, and research organisations.

News

Pfizer is creating the role of AI Scholar for computational biologist Eric Schadt, who is leaving Pathos AI to start a new stealth venture.

R&D

In June/July, companies continued to reshape their leadership teams in preparation for upcoming clinical, regulatory, and commercial milestones.

R&D

Looking back to May, the pharma and biotech sector saw a steady stream of senior leadership changes.

R&D

April didn’t see too much activity at the big pharmas, but saw plenty of executive movement at small and midsized biotechs.